Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
Top Cited Papers
Open Access
- 1 March 2011
- journal article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 6 (3), 451-458
- https://doi.org/10.1097/jto.0b013e31820517a3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Rebiopsy of Lung Cancer Patients with Acquired Resistance to EGFR Inhibitors and Enhanced Detection of the T790M Mutation Using a Locked Nucleic Acid-Based AssayClinical Cancer Research, 2011
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I TumorsThe American Journal of Surgical Pathology, 2010
- Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized TreatmentsInternational Journal of Surgical Pathology, 2009
- Reliability of cytologic diagnosis of early lung cancerCancer, 2007
- KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or ErlotinibPLoS Medicine, 2005
- Pathology of small cell carcinoma of the lungSeminars in Oncology, 2003
- Diagnostic value and cost‐effectiveness of on‐site evaluation of fine‐needle aspiration specimens: Review of 5,688 casesDiagnostic Cytopathology, 2002
- Accuracy of bronchial aspiration cytology in typing operable (stage I-II) pulmonary carcinomasDiagnostic Cytopathology, 1992
- Cytological features of non-small cell carcinomas of the lung in fine needle aspirates.Journal of Clinical Pathology, 1991
- Diagnostic Accuracy of Exfoliative Pulmonary CytologyThe Annals of Thoracic Surgery, 1970